Y Intercept (Hong Kong) LTD Nautilus Biotechnology, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 224,456 shares of NAUT stock, worth $145,896. This represents 0.0% of its overall portfolio holdings.
Number of Shares
224,456Holding current value
$145,896% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding NAUT
# of Institutions
75Shares Held
63.2MCall Options Held
158KPut Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$10.6 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$8.19 Million0.4% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$4.66 Million0.16% of portfolio
-
Madrona Venture Group, LLC6.02MShares$3.91 Million34.58% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$2.49 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $81M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...